Adagio Medical Holdings, Inc.
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) is a medical device company developing and commercializing catheter-based products for cardiac arrhythmias, with an initial focus on ventricular tachycardia (VT). Its proprietary ultra-low temperature ablation (ULTA) technology is designed to create deep, durable… From the company’s description.
In fiscal 2025, Adagio Medical Holdings, Inc. reported a net loss of $25.08M. Operations used $19.01M in cash.
Dotted labels explain each measure. is shown separately from the annual figures.
What Adagio Medical Holdings, Inc. does
In the company’s own words
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) is a medical device company developing and commercializing catheter-based products for cardiac arrhythmias, with an initial focus on ventricular tachycardia (VT). Its proprietary ultra-low temperature ablation (ULTA) technology is designed to create deep, durable heart-tissue lesions, and its vCLAS Cryoablation System combines an ablation catheter and console for VT procedures. The system has CE Mark approval in Europe; its U.S. pivotal FULCRUM-VT study completed enrollment in 2025. Adagio is also developing the next-generation vCLAS ULTRA catheter and pulsed field cryoablation (PFCA), which combines ULTA with pulsed field ablation. The company’s technology portfolio includes ULTA and PFCA, with product families branded vCLAS for ventricular ablation, iCLAS for atrial ablation, and Cryopulse for PFCA. Its customers are healthcare providers performing cardiac ablation procedures, including electrophysiology centers and physicians. Adagio reports a single business focused on developing and commercializing cardiac ablation products. Its website is www.adagiomedical.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Surgical & Medical Instruments
- Headquarters
- LAGUNA HILLS, CA
- Fiscal year end
- December
- CIK
- 2006986
- SIC
- 3841
Financial performance, year by year
Fiscal 2025–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Adagio Medical Holdings, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Adagio Medical Holdings, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Could not be determined for this company: bond issues.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Adagio Medical Holdings, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Adagio Medical Holdings, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Adagio Medical Holdings, Inc.'s last four quarterly filings that the numbers alone won't show?”